SAT1 and acute myeloid leukemia: We selected 8 drugs (ARRY-162, Cobimetinib, Mitomycin, lrofulven, Tamoxifen, Oxaliplatin, Fulvestrant and lmatinib) that AML patients with dysregulation of SAT1, G6PD or CD44 may be sensitive to.